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Abstract 
Up to 50% of infants present with symptoms of regurgitation, infantile colic and, or, 
constipation during the first 12 months of life. Although they are often classed as 
functional disorders, there is an overlap with cows’ milk allergy. We present practical 
algorithms for the management of such disorders, based on existing evidence and 
general consensus, with a particular focus on primary healthcare. Management 
consists of early recognition of warning signs of organic disease, parental 
reassurance and nutritional strategies. Conclusion. The proposed algorithms aim to 
help healthcare providers manage frequent gastrointestinal and cows’ milk related 
symptoms in infants safely and effectively.  
 
Key Notes 
• Up to 50% of all infants present with symptoms of regurgitation, infantile colic 
and, or, constipation during the first 12 months of life.  
• We present practical algorithms for the management of frequent 
gastrointestinal and cows’ milk related symptoms, based on existing evidence 
and general consensus, with a particular focus on primary healthcare.  
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• The algorithms focus on early recognition of the warning signs of organic 
disease, parental reassurance and nutritional strategies.  
 
INTRODUCTION 
Although functional gastrointestinal disorders (FGID), such as regurgitation, infantile 
colic and constipation, are considered to be benign conditions, they occur in up to 
50% of infants and are often frustrating for parents and carers. Each of these FGIDs 
occurs in 20-25% of infants, who may present with a combination of symptoms (1).  
Functional gastrointestinal symptoms are considered to be transient, self-limiting 
conditions. However, limited data suggest that symptoms such as infantile colic may 
be associated with recurrent abdominal pain, migraine, allergic disorders, sleep 
disturbances and maladaptive behaviour, such as aggressiveness, later in life (2).  
The Rome III consensus has proposed diagnostic criteria for these symptoms, but 
not for the management of them (3). Functional gastrointestinal symptoms are not a 
reason to stop breastfeeding and almost half of all infants who are formula-fed have 
at least one change of formula because of gastrointestinal symptoms during their 
first six months of life (4). This reflects the anxiety of parents and the search for a 
remedy by both the parents and the doctors. The natural course of these symptoms 
is for them to spontaneously disappear. 
Children with cows’ milk allergy (CMA) can present with one or more of the above symptoms 
and the clinical discrimination between FGID and CMA may be challenging (5). Symptoms of 
CMA are non-specific (5) and it is difficult for primary healthcare providers to diagnose CMA. 
Therefore, the preferred terminology is cows’ milk related symptoms, as this does not 
differentiate between FGID and CMA as the cause of the symptoms. Because of the long-
term impact of a diagnosis of CMA on later health, such as an increased risk for other atopic 
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manifestations or diseases (6), this diagnosis should only be made by specialists such as 
paediatric allergists or appropriately experienced gastroenterologists. Asthma, allergic 
rhinitis and eczema are more common in children with a history of CMA than would be 
expected in the general population (6). While the self-reported lifetime prevalence of CMA is 
6% (5.7-6.4), the prevalence of CMA defined by a positive food challenge is only 0.6% (0.5-
0.8) (7).  
This paper gives practical advice that will enable primary healthcare providers to 
recognise and manage common FGID and cows’ milk related symptoms in infants 
more effectively. Practical recommendations and algorithms have been developed 
and discussed. These may need to be adapted to account for local circumstances 
and individual patient situations.  
 
Methods  
The authors did not aim to replace the evidence-based guidelines of the North American 
Society of Paediatric Gastroenterology, Hepatology and Nutrition Society of Paediatric 
Gastroenterology, Hepatology and Nutrition (NASPGHAN) or the European Society of 
Paediatric Gastroenterology, Hepatology and Nutrition (ESPGHAN) on CMA, gastro-
oesophageal reflux (GOR) or constipation (5,8,9). We searched MEDLINE, Embase, the 
Cochrane Database of Systematic Reviews, the Cochrane Central Register of Controlled 
Clinical Trials and PubMed from the end of the literature searches mentioned in the 
ESPGHAN guidelines on cow's milk allergy (2012) and the NASPGHAN/ESPGHAN 
guidelines on gastro-oesophageal reflux and constipation (2009 and 2014, respectively) up 
to October 2014. With regard to infantile colic, the literature was searched for papers not 
included in three systematic reviews (10,11,12). Our paper provides a follow-up of the 
consensus algorithms that were developed by Belgian paediatric gastroenterologists (13). 
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The authors of this paper, who come from different parts of the world, made 
recommendations based on the evidence, when it was available, and on the consensus if 
the evidence was missing. The practical recommendations contained in this paper should be 
applicable worldwide.      
 
In November 2014 the Gastroenterology Committee of ESPGHAN discussed the contents of 
this paper in detail and voted on the statements during a face-to-face meeting. This group 
decided to include additional key opinion leaders, who participated in electronic discussions 
and voting. Finally, the statements were given to another selected group of experts who only 
participated in the voting. As a result, 22 key opinion leaders from different regions of the 
world participated in the voting.  
In order to reach a consensus, we used a structured method that had previously been shown 
to be effective (9,14). Consensus was formally achieved through a nominal group technique, 
which is a structured quantitative method. The group consisted of 22 members who voted 
anonymously. Before the voting took place, the statements were reviewed by each co-author 
until agreement was reached. A nine-point scale was used, ranging from one for strongly 
disagree to nine for fully agree (15). It was decided beforehand that consensus was deemed 
to be reached if more than 75% of the votes were scores of six, seven, eight or nine. A vote 
of six and above meant agreement, with nine being an expression of stronger agreement 
than six.  
 
Regurgitation  
Regurgitation, the passage of refluxed gastric contents into the pharynx or mouth, is 
physiological. Most regurgitation episodes occur during the postprandial period and cause 
few or no other symptoms (8). The five statements related to regurgitation and the 
associated voting results are listed in Table 1.  
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According to the Rome III criteria, regurgitation in an infant of between three weeks and 12 
months of age includes: regurgitation two or more times per day for three weeks or more and 
an absence of nausea, hematemesis, aspiration, apnoea, failure to thrive, difficulty in feeding 
or swallowing and abnormal posture (3). More than 50% of three to four-month-old infants 
regurgitate daily, fulfilling the Rome III criteria (8). At least two studies have showed that four 
or more episodes of regurgitation occurred in about 20% of all infants and that 20% of 
mothers sought medical help for this (8). Investigations are not recommended to diagnose 
regurgitation. Differential diagnoses should be considered in infants who are younger than 
one week and older than six months, as physiological regurgitation rarely starts before the 
age of one week or after six months (8).  
 
The management of regurgitation is as follows (Figure S1). In infants with frequent and 
troublesome regurgitation, a complete medical history and physical examination is warranted 
to rule out organic disease. As physiological regurgitation should not be diagnosed in an 
infant with vomiting and poor weight gain, anthropometry is of major importance (8). The 
management of regurgitation starts with reassuring parents, by providing information on the 
natural history of regurgitation and correct formula preparation if the infant is not breastfed, 
together with advice on how overfeeding may exacerbate symptoms (8). Regurgitation is not 
a reason to stop breastfeeding. The nutritional management of regurgitation consists of 
correcting the frequency and volume of feeds, if necessary (8). Thickened formula or anti-
regurgitation formula decreases regurgitation (8). Placing infants in a prone, anti-
Trendelenburg position cannot be recommended because of the risk of sudden infant death 
syndrome (SIDS) (8). However, there is limited evidence for some efficacy of an anti-
regurgitation bed with an angle of 40° anti-Trendelenburg (16). Putting the infant to sleep on 
its side has also been recommended, but is associated with an intermediate risk of SIDS, 
between prone and supine sleeping (17). Proton pump inhibitors do not decrease infant 
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regurgitation, crying, distress or irritability (18). There is no indication for drug treatment in 
‘happy spitters’ or in infants with troublesome regurgitation. 
Commercial anti-regurgitation formulae contain different thickening agents, such as 
processed rice, corn or potato starch, guar gum or locust bean gum. If a commercial anti-
regurgitation formula is not available, a thickening product may be added to standard 
formula. Cereals increase the infants’ caloric intake, possibly inducing excessive weight gain 
and altering the fat and protein energy ratio. Locust bean gum does not increase the caloric 
density, but may cause bloating (19). Home thickening of a regular formula increases the 
osmolarity, which may in itself induce reflux by increasing the number of transient lower 
oesophageal sphincter relaxations (8). Infants with persistent regurgitation and, or, vomiting 
should be referred to a paediatric gastroenterologist (8). 
 
A limited number of studies have suggested that specific probiotics, namely Lactobacillus 
(L.) reuteri DSM 17938, and prebiotics prevent regurgitation (20,21). L. reuteri DSM 17938 
accelerates gastric emptying. The gastric emptying of a partial protein hydrolysate is faster 
than that of intact protein, which may decrease regurgitation (22). CMA should be suspected 
in an infant with persistent and recurrent regurgitation, especially when it is associated with 
other manifestations of allergic disease, such as atopic dermatitis and, or, wheezing. These 
infants should be referred to a paediatric allergist for appropriate diagnosis and 
management.  
 
Infantile colic  
The historic definition of infantile colic consists of crying lasting three or more hours a day, at 
least three days a week for at least three weeks (3). The six statements related to infantile 
colic, and their voting results, are listed in Table 2. In 2006, the Rome III criteria defined 
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infantile colic as: “episodes of irritability, fussing or crying that begin and end for no apparent 
reason and last at least three hours a day, at least three days a week, for at least one week 
in an apparently healthy infant with a normal clinical examination” (3). According to a 
thorough analysis of the literature, the median incidence of infantile colic was about 30% 
(23) and it was reported to occur as frequently in breast as bottle-fed infants and equally in 
both sexes. 
 
The cardinal manifestation of infantile colic is excessive, persistent, inconsolable or 
unsoothable loud crying, especially in the late afternoon. During each episode the child 
appears irritable, distressed and fussy, flexes the hip joints, becomes red-faced and has 
episodes of borborygmi. Multiple aetiologies have been proposed. These include altered 
gastrointestinal function, food intolerance, transient low lactase activity, CMA, GOR or GOR 
disease, intestinal dysbiosis, parental coping, anxiety, depression, absence of mother–child 
reciprocity and the risk of child abuse.  
 
The management of infantile colic is as follows (Figure S2). There are no uniform 
criteria for a specific therapeutic approach. The first recommended step is to look out for 
potential warning signs that may indicate organic disease. If these are not present, the 
feeding technique should be evaluated and the carers should be reassured and supported. 
Parents should be educated to recognise signs of hunger and fatigue and instructed about 
structure and regularity. General advice emphasising the self-limiting nature of the condition 
is important.  
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Cows’ milk elimination and other dietary interventions  
Infantile colic is not a reason to stop breastfeeding. However, in selected infants with 
excessive irritability and crying it may be recommended that the lactating mother excludes 
dairy products for two to four weeks and then reintroduces them. In selected formula-fed 
infants, there is some evidence that an extensively hydrolysed protein formula reduces 
infantile colic (10). If the diagnosis of CMA cannot be made by a specialist it is preferable to 
consider infantile colic as a cows’ milk related symptom.  
 
With regard to other dietary interventions, soy-based formula is not recommended, although 
low-quality studies have reported a reduction in crying time (10). Reviews have suggested 
that partially hydrolysed protein formula could be beneficial if CMA is not a potential cause of 
infantile colic (10,24). These formulae are often lactose-reduced or lactose-free and contain 
prebiotics or probiotics, which may have contributed to a reduction in crying time (10).  A 
meta-analysis showed that L. reuteri DSM 17938 reduced infantile colic in exclusively 
breastfed infants (12), while a study in mainly formula-fed infants did not show this (25). One 
study also showed a reduction in maternal depression (26). The same probiotic strain was 
shown to significantly prevent the onset on infantile colic in formula and breastfed infants 
(20,28).  
 
A Latin-American expert group concluded that there was grade 1a evidence for L. reuteri 
DSM 17938 in the prevention of infantile colic and grade 1b evidence for its treatment, 
although the mechanism of action that explains the efficacy of this probiotic remains unclear 
(28). However, these findings should not be extrapolated to other probiotics, as the efficacy 
was only demonstrated in breastfed infants and there were no data relating to the probiotic 
being added to infant formula. Therefore, the use of L. reuteri DSM 17938 in IC should be 
considered, but is not recommended.     
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Although the addition of prebiotics and probiotics to infant formula has not been shown to 
decrease infantile colic, the evidence seems slightly better for beta-palmitate. One double-
blind, placebo-controlled trial, showed a significant decrease in infantile colic within one 
week of intervention with a partial hydrolysate, with high β-palmitate and a specific prebiotic 
mixture of galacto and fructo-oligosaccharides (29). However, one trial was considered 
insufficient for a recommendation.  
 
Lactase or reduced lactose are other dietary options that have been explored. A limited 
number of studies have suggested that transient low lactase activity could trigger excessive 
crying (10,30). Lactose-free or soy-based formulae have not been consistently demonstrated 
to be beneficial for patients with infantile colic. The selection of patients is likely to be a major 
bias in these studies. After some initial enthusiasm about the role of lactase treatment, 
negative results have suggested that lactose plays a minor role in infantile colic (10). 
Although a UK recommendation suggested a one-week trial of lactase drops in breastfed 
and formula-fed infants, the evidence for this recommendation was limited (31). A 
preventative trial with a formula containing a stable lactase as the result of a fermentation 
process indicated a decreased incidence of infant crying at the age of four weeks (32). There 
was insufficient evidence to recommend a trial of lactase or reduced lactose formula in every 
infant presenting with infantile colic, although this was a safe intervention. 
 
Medication  
Proton pump inhibitors have failed to decrease infant distress in infantile colic (18). Anti-acid 
medications were not indicated in infantile colic when GOR disease was not diagnosed. 
Cimetropium caused lethargy, motion sickness and somnolence (33). Hypertonic glucose 
solutions showed varying effects on crying time (35). Fennel extracts and sucrose solutions 
had some benefit (35). Allopathic drugs were not proved to be effective (simethicone) and 
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some of them caused serious adverse reactions (dicyclomine) (36). In a double-blind study, 
mentha piperita was shown to reduce infantile colic (37). An extract of Matricariae recutita, 
Foeniculum vulgare and Melissa officinalis improved infantile colic in breastfed infants (38). 
However, evidence was too limited to recommend the use of any of these herbal medicinal 
products for infantile colic.  
 
Swaddling and other caregiving interventions 
There was insufficient evidence to systematically recommend swaddling, although the 
technique was reported to be of some benefit in infants who were less than eight weeks old 
(39). Studies have evaluated the role of carers’ support, counselling therapy, car rides during 
colic episodes and a reduction in stimulating actions such as changing diapers and 
chiropractic and spinal massages. Unfortunately, none of these trials were of sufficient 
methodological quality (10).  
 
Our conclusion about infantile colic 
Infantile colic is a multi-factorial condition and it is unlikely that a single intervention will 
significantly reduce it in an unselected population. In infants with proven CMA and infantile 
colic, the correct treatment is extensively hydrolysed formula or,  
if that cannot be tolerated, an amino acid-based formula (5). There has been insufficient 
evidence to enable us to recommend a trial with L. reuteri DSM 17938 or lactase, although 
neither induced adverse effects.  
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Constipation 
Healthcare practitioners must be aware of normal infant defecation patterns in order to 
adequately educate and advise parents (3). One study showed that infants who had colic 
symptoms in the first two months had less frequent defecation during the first two years of 
life (40). The second month of life was unique in the sense that the frequency of stooling 
decreased to half of the previous month (40). The four statements related to constipation, 
and their voting results, are listed in Table 3.  
 
Information should be obtained regarding the duration of the condition, the frequency of 
bowel movements, the consistency, colour and size of the stools, whether defecation is 
painful and the presence of blood and mucus. This information will help to make the 
distinction between functional constipation and constipation due to organic disease. The 
Amsterdam stool scale may be a useful tool (9). According to the Rome III criteria, the 
definition of functional constipation includes at least two of the following criteria in an 
apparently healthy infant: i) two or fewer defecations per week; ii) at least one episode per 
week of incontinence after the acquisition of toileting skills (not relevant in infants); iii) history 
of excessive stool retention; iv) history of painful or hard bowel movements; v) presence of a 
large faecal mass in the rectum; vi) history of large-diameter stools that may obstruct the 
toilet (not relevant in infants) (3). 
 
Crying and straining associated with defecation of soft stools in otherwise healthy infants 
who are less than six months of age is defined as functional dyschezia, which is a different 
condition from constipation. Dyschezia resolves with time without the need for any 
intervention (3).  
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Hard stools occur in only 1% of exclusively breastfed infants compared to 9.2% of standard 
formula-fed infants who do not receive prebiotic or probiotic supplements. (9). While 
breastfed infants generally produce soft stools ranging from one per week up to six or eight 
per day, extremes of up to 12 times a day or once every three to four weeks have been 
reported (3,9). Firm or hard stools often occur when breast milk is switched to infant formula 
or after the introduction of solids. Harder stools are frequent in infants fed with formula 
containing vegetable oil that is rich in palmitic acid that is found mainly at the stereospecific 
numbering (Sn) positions Sn-1 and Sn-3. In mother’s milk, palmitic acid is mainly in the Sn-2 
position (9). The Sn-1 and Sn-3 positions favour the formation of calcium soaps, responsible 
for the hard stools, whereas the Sn-2 position is not associated with this problem.  
 
The prevalence rate for constipation in the first year of life has been reported to be 2.9%, 
increasing up to 10.1% in the second year (9).  
 
Infants under one year of age are referred for suspected functional constipation because of 
pain, consistency and frequency of stools. Accompanying symptoms may include irritability, 
decreased appetite and early satiety, which rapidly disappear after passing stools (3,9).  
 
The management of constipation is as follows  (Figure S3). A thorough medical history and 
physical examination are the cornerstones for diagnosing functional constipation. Failure to 
pass meconium within 24 hours of birth should raise suspicion of Hirschsprung’s disease or 
cystic fibrosis (9). If an organic cause is not suspected, there is no indication for laboratory or 
radiographic testing (9). The patient should be referred if they are failing to thrive, have 
intermittent diarrhoea or abdominal distension (9). At some time in the clinical assessment, 
every infant with functional constipation should have a digital rectal examination (9). The 
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anorectal examination should evaluate perianal sensitivity, anal calibre, position and tone 
and the presence of an anal wink, fissure or prolapse (3,9). 
 
The first step in the management of functional constipation is parental education and 
reassurance (3,9). If the probability of an organic condition is low, reassurance and close 
follow-up are sufficient. Dietary changes and corn syrup resolve constipation in 25% of 
cases and laxatives work in 92% (9). In some infants constipation is related to the intake of 
CMP, although there is no consensus that extensively hydrolysed formula or soy formulae 
are indicated for all constipated infants (9). In children with food-related chronic constipation, 
an increase in both rectal mast cell density and spatial interactions between mast cells and 
nerve fibres correlates with anal motor abnormalities (41).  
 
In infants who are not constipated, using a formula enriched with prebiotics and, or, 
probiotics increases the frequency of defecation and softens the stools (42,43). An 
underpowered study performed with a partial hydrolysate, a prebiotic and β-palmitate, which 
is palmitic acid enriched at the Sn-2 position, showed a trend for a softer stool consistency 
(44).  
 
There is no evidence to support the use of mineral water rich in magnesium to prepare infant 
formula. Some anti-constipation formulae have a high content of magnesium, albeit within 
the regulatory limits (9,45). L. reuteri DSM 17938 increases stool frequency in normal infants 
(20), but only one study has shown that L. reuteri DSM 17938 increased bowel movements 
in constipated infants, without any difference in consistency and crying episodes (46).  
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Lactulose is effective, but causes flatulence (9). Both milk of magnesia and polyethylene 
glycol are efficient and safe for infants and toddlers (47). Polyethylene glycol is registered in 
most countries from the age of six months, is at least as effective as lactulose and causes 
fewer side effects (9).  
 
Juices containing sorbitol, such as prune, pear and apple juices, decrease constipation but 
induce a risk of unbalanced nutrition (9). Glycerine suppositories can be helpful if acute relief 
from rectal emptying is needed (9). Evidence does not support the use of mineral oil, as this 
risks lipoid pneumonia due to aspiration, or enemas such as phosphate in young infants (9).  
 
The role of cows’ milk related symptoms and CMA  
CMA is significantly less common than the FGIDS discussed above and occurs in 
only 3-5% of formula-fed infants and in 0.5% of breastfed infants (5,13). Three 
related statements and their voting results are listed in Table 4. CMA often presents 
with gastrointestinal manifestations such as regurgitation, vomiting and abnormal 
defecation, although these are rarely the single manifestation. Most infants with CMA 
present a combination of symptoms involving different organ systems. Symptoms of 
CMA and FGID overlap and diagnostic tests do not reliably differentiate between 
both of them. Therefore, if the diagnosis of CMA cannot be confirmed by a specialist, 
it is preferable to designate these symptoms as cows’ milk related. A decrease of 
symptoms with an extensively hydrolysed formula should not be considered as proof 
of CMA, as gastric emptying is enhanced and stools are softer when this is 
administered (48).  
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Classification and clinical features 
According to the definition proposed by the World Allergy Organization, CMA is a 
hypersensitivity reaction caused by specific immunological mechanisms to one or more of 
the proteins present in cows’ milk (49). IgE-mediated CMA is characterised by an immediate 
reaction and is often associated with atopic dermatitis, asthma, and, or, allergic rhinitis. 
Gastrointestinal symptoms such as regurgitation, vomiting, colic and diarrhoea accompany 
systemic manifestations of the skin such as urticaria and angio-oedema and the respiratory 
tract such as rhinitis, wheezing and stridor. There are also shock-like symptoms, which occur 
usually within minutes or up to two hours later (5,13). Mixed immunoglobulin E (IgE) and 
non-IgE mediated CMA constitute a group of disorders that are well defined clinically, but 
their immunological mechanisms are not well understood. Most of the gastrointestinal 
symptoms are non-IgE mediated, making it difficult to differentiate functional gastrointestinal 
symptoms from CMA. Children with a positive food challenge often present with one or more 
FGIDs. Therefore, it is more appropriate for primary healthcare practitioners to consider that 
these symptoms are related to the ingestion of CMP rather than proof of CMA.   
 
Diagnosis and management of CMA and cow's milk related symptoms 
Eliminating cows’ milk and then carrying out an oral challenge is the standard 
diagnostic test for CMA or for any symptom related to the ingestion of cows’ milk 
protein. Both over-diagnosis and under-diagnosis have an adverse impact on the 
child’s growth (50). Skin prick testing and specific IgE tests indicate sensitisation to 
cows’ milk protein, while negative tests do not exclude CMA (5,51).  Total IgE has a 
poor specificity for the diagnosis of CMA. Specific IgE and the diameter of the skin 
prick testing provide information on the prognosis: the higher the specific IgE and, or, 
the larger the diameter of the skin reaction, the longer it will take until tolerance to 
CMP develops (52). Atopy patch testing is not a recommended procedure (5).  
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Children with cows’ milk related symptoms or CMA should be monitored for the 
development of tolerance through repeated oral food challenges (5).  
 
Regarding formula replacement, many guidelines have recommended extensively 
hydrolysed formula as the first option (5,13,52,53). We refer to previously published 
algorithms (5). According to the World Allergy Organization guidelines, Diagnosis and 
Rationale for Action against Cows’ Milk Allergy recommend extensively hydrolysed formula 
over soy formula in IgE-mediated CMA, but stress the need for more data, stating: “there is 
very sparse evidence suggesting a possible benefit from using eHF compared to soy 
formula” (49). There is limited evidence that the addition of prebiotics or probiotics, namely L. 
rhamnosus GG or Bifidobacteria breve, to an extensively hydrolysed formula offer any 
additional benefits (53,54). In an open study, it was suggested that L. rhamnosus GG 
induced more rapid tolerance (53). However, results from an open study provide insufficient 
evidence for a recommendation.  
 
Soy is the second option, especially if extensively hydrolysed formula is not available, if it is 
too expensive or if the child refuses to drink it (5). The Agence Française de Sécurité 
Sanitaire des Aliments underlined the limited knowledge and uncertainties regarding the 
presence of isoflavones in soy formulae (55). The American Academy of Pediatrics 
concluded that 10% to 14% of infants with CMA would become sensitised to soy and that 
this happened more frequently in non-IgE mediated CMA (56). According to a recent meta-
analysis the prevalence of soy allergy was 0.5 % in the general population, but the 
prevalence of sensitisation after the use of soy infant formula was 8.7 % (57). The risk of 
developing sensitisation to soy should be considered according to the cost-efficacy-risk ratio, 
which differs according to the socio-economic situation. Although soy protein has been used 
in infant feeding for more than 100 years, its popularity varies substantially in different parts 
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of the world (57). Soy based infant formula has a high content of isoflavones, which have 
been shown to induce oestradiol-like effects in animal models (58). 
 
Extensive hydrolysates from rice protein, which are on the market in a growing number of 
countries, may gain greater scientific support as the evidence of their efficacy is growing (59) 
and they are cheaper than extensively hydrolysed formula. However, the level of arsenic 
content in rice-based infant formula should be declared (60). 
 
Although regurgitation, constipation or infantile colic in infants may be related to the 
ingestion of CMP, the immune mechanisms involved can rarely be demonstrated. 
Therefore, these infants should not be considered as suffering from CMA but as 
infants presenting with cows’ milk ingestion related symptoms. It is important that the 
healthcare practitioner explains this to the parents, as the long-term outcomes of 
CMA or food-related symptoms differ.     
 
CONCLUSION 
Infants presenting with gastrointestinal problems such as regurgitation, infantile colic and, or, 
defecation problems often undergo a series of unnecessary investigations and medical 
treatments. Overall, medication has failed to deliver significant improvements in these 
conditions. The practical algorithms presented in this paper focus on reassurance, education 
and dietary intervention and will assist primary healthcare practitioners in the diagnosis and 
management of functional gastrointestinal manifestations in infants who are less than 12 
months old. The diagnosis and management of CMA are challenging because there are no 
specific symptoms or diagnostic tests available, other than dietary exclusion and oral 
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challenges. Our proposed algorithms are based on the evidence, when it was available, and 
expert consensus when evidence was not available.   
 
 
Abbreviations: 
CMA, cows’ milk allergy; ESPGHAN, European Society of Paediatric Gastroenterology, 
Hepatology and Nutrition); FGID, functional gastrointestinal disorders; GOR, gastro-
oesophageal reflux; IgE, immunoglobulin E; NASPGHAN, North American Society of 
Paediatric Gastroenterology, Hepatology and Nutrition Society of Paediatric 
Gastroenterology, Hepatology and Nutrition.  
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Table 1. Statements and voting results on regurgitation 
Stat  Consensus Mean 
1 Otherwise healthy infants, who present with four or more 
episodes of regurgitation per day during at least two 
weeks, and in whom the onset is either after the age of 
one week or before the age of six months, should be 
considered as presenting with physiologic regurgitation 
and should be managed by parental reassurance. (≥4 
episodes/d, > 2 weeks duration; onset > 1 week and  < 6 
months of age). 
Yes (19/22) 
Agree: 86% 
7.36 
2 Diagnostic investigations are not indicated for the 
diagnosis and management of “troublesome 
regurgitation”. 
Yes (20/22) 
Agree: 91% 
7.36 
3 Anti-regurgitation formula may be considered in infants 
with physiologic regurgitation. 
Yes (20/22) 
Agree: 91% 
7.41 
4 Drug treatment is not indicated in the management of 
physiologic regurgitation. 
Yes (22/22) 
Agree 100% 
8.68 
5 Drug treatment is not indicated in the management of 
physiologic and troublesome regurgitation. 
Yes (17/22) 
Agree 77% 
7.18 
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Legend: Stat: statement 
 
Table 2. Statements and voting results on infantile colic 
Stat  Consensus Mean 
6 Evidence suggests that the use of extensively 
hydrolysed infant formula for a formula fed baby and a 
cows’ milk free diet for a breastfeeding mother may be 
beneficial to decrease infantile colic. However, these 
data reflects selected infant populations. 
Yes (21/22) 
Agree 95% 
7.73 
7 There is convincing data that L. reuteri DSM 17938 
decreases infantile colic in well selected breastfed 
infants. 
Yes (19/22) 
Agree 86% 
7.54 
8 However, there is insufficient data to recommend L. 
reuteri DSM 17938 in all colicky infants. 
Yes (21/22) 
Agree 95% 
8.32 
9 Anti-acid medications are not indicated for colicky infants 
without manifestations of gastro-esophageal reflux 
disease. 
Yes (22/22) 
Agree 100% 
8.73 
10 There is limited data reporting positive effects of herbal 
medicine, such as fennel and peppermint for treatment 
of colicky infants. 
No (15/22) 
Agree 68% 
6.54 
11 However, the evidence of benefit is too limited to 
recommend herbal medicine such as fennel and 
peppermint for alleviating infantile colic. 
Yes (22/22) 
Agree 100% 
8.36 
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Legend: Stat: statement; italic: statements on which consensus was not reached 
Table 3. Statements and voting results on infant constipation 
Stat  Consensus Mean 
12 Lactulose may be considered as an intervention for 
functional constipation. 
Yes (21/22) 
Agree 95% 
8.09 
13 Macrogol (polyethylene glycol, PEG) may be considered 
as an intervention for functional constipation for infants 
over six months of age. 
Yes (21/22) 
Agree 95% 
8.36 
14 An extensively hydrolysed infant formula may be 
considered as an intervention for functional constipation 
for two to four weeks, followed by a challenge with 
standard cows’ milk infant formula in formula fed infants. 
No (16/22) 
Agree 73% 
6.27 
15 Rectal treatment with glycerine suppository should be 
restricted to providing acute relief in functional 
constipation. 
Yes (20/22) 
Agree 91% 
7.82 
 
Legend: Stat: statement; italic: statements on which consensus was not reached 
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Table 4. Statements and voting results on CMA  
 
Stat  Consensus Mean 
16 The first treatment choice of CMA in formula fed infants 
is an extensive cows’ milk based hydrolysate. 
Yes (22/22) 
Agree 100% 
8.64 
17 If extensive cow's milk based hydrolysates are not 
available, too expensive or not accepted or tolerated 
because of the taste, extensive rice hydrolysates and, 
or, soy infant formulae are a valid second choice. 
Yes (20/22) 
Agree 91% 
7.91 
18 There is insufficient data to state that soy based infant 
formula would be more unsafe for infants younger than 
six months than for older infants. 
Yes (20/22) 
Agree 91% 
7.36 
 
Legend: Stat: statement 
 
 
